The Association Between Arg72Pro C>G Polymorphism in the
p53 Gene and the Risk of Obesity

Kaya, Zehra; SOYOCAK, Ahu; Alis, Halil; Koc, Gulsah

doi:10.4274/imj.galenos.2022.64624

The Association Between Arg72Pro C>G Polymorphism in the p53 Gene and the Risk of Obesity

Gülşah , (İstanbul Aydın Üniversitesi Tıp Fakültesi, Tıbbi Biyoloji Anabilim Dalı, İstanbul, Türkiye)

Ahu SOYACAK, (İstanbul Aydın Üniversitesi Tıp Fakültesi, Tıbbi Biyoloji Anabilim Dalı, İstanbul, Türkiye)

Zehra KAYA, (Van Yüzüncü Yıl Üniversitesi Tıp Fakültesi, Tıbbi Biyoloji Anabilim Dalı, Van, Türkiye)

Halil ALİS (İstanbul Aydın University VM Medical Park Florya Hospital, Clinic of General Surgery, İstanbul, Turkey)

İstanbul Medical Journal

6 0

Yıl: 2022 Cilt: 23 Sayı: 1 Sayfa Aralığı: 55 - 59 Metin Dili: İngilizce DOI: 10.4274/imj.galenos.2022.64624 İndeks Tarihi: 18-06-2022

The Association Between Arg72Pro C>G Polymorphism in the p53 Gene and the Risk of Obesity

Öz:

Introduction: The role of genetic factors in obesity has long been recognized, but their involved specific genes remained unidentified. The relationship between p53 gene single nucleotide polymorphisms and the risk of obesity has been investigated in recent years. Therefore, this study aimed to investigate the association of p53 Arg72Pro C>G (rs1042522) polymorphism with the risk of obesity in our study. Methods: This study included 52 patients with obesity (26 were females and 26 were males) and 52 normal-weight healthy controls. Genomic DNA isolation was performed from the blood samples of all participants. P53 Arg72Pro C>G (rs1042522) polymorphism was detected by real-time quantitative polymerase chain reaction from genomic DNA samples. Results: No significant associations were identified between Arg72Pro (rs1042522) P53 polymorphism and obesity risk. Glucose levels are significantly different between the obese and control groups with the CC and CG genotypes, but without difference in the GG homozygous genotype. Conclusion: Our study is one of the first to investigate the relationship between p53 codon 72 polymorphisms and obesity risk but revealed no correlation between them. The relatively small number of participants may limit our study. Further research is needed in a large cohort to associate the p53 gene Arg72Pro C>G (rs1042522) variant with obesity risk.

Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. González-Muniesa P, Mártinez-González MA, Hu FB, Després JP, Matsuzawa Y, Loos RJF, et al. Obesity. Nat Rev Dis Primers 2017; 3: 17034.
2. Wright SM, Aronne LJ. Causes of obesity. Abdom Imaging 2012; 37: 730-2.
3. Zwezdaryk K, Sullivan D, Saifudeen Z. The p53/Adipose-Tissue/ Cancer Nexus. Front Endocrinol (Lausanne) 2018; 9: 457.
4. Strycharz J, Drzewoski J, Szemraj J, Sliwinska A. Is p53 Involved in Tissue-Specific Insulin Resistance Formation? Oxid Med Cell Longev 2017; 2017: 9270549.
5. Schwartzenberg-Bar-Yoseph F, Armoni M, Karnieli E. The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression. Cancer Res 2004; 64: 2627-33.
6. Goldstein I, Rotter V. Regulation of lipid metabolism by p53 - fighting two villains with one sword Trends Endocrinol Metab 2012; 23: 567- 75.
7. Molchadsky A, Ezra O, Amendola PG, Krantz D, Kogan-Sakin I, Buganim Y, et al. p53 is required for brown adipogenic differentiation and has a protective role against diet-induced obesity. Cell Death Differ 2013; 20: 774-83.
8. Gloria-Bottini F, Banci M, Saccucci P, Magrini A, Bottini E. Is there a role of p53 codon 72 polymorphism in the susceptibility to type 2 diabetes in overweight subjects? A study in patients with cardiovascular diseases. Diabetes Res Clin Pract 2011; 91: e64-e67.
9. Chen RH, Chang CT, Wang TY, Huang WL, Tsai CH, Tsai FJ. p53 codon 72 proline/arginine polymorphism and autoimmune thyroid diseases. J Clin Lab Anal 2008; 22: 321-6.
10. Pim D, Banks L. p53 polymorphic variants at codon 72 exert different effects on cell cycle progression. Int J Cancer 2004; 108: 196-9.
11. Burgdorf KS, Grarup N, Justesen JM, Harder MN, Witte DR, Jorgensen T, et al. Studies of the association of Arg72Pro of tumor suppressor protein p53 with type 2 diabetes in a combined analysis of 55,521 Europeans. PLoS One 2011; 6: e15813.
12. Marin MC, Jost CA, Brooks LA, Irwin MS, O’Nions J, Tidy JA, et al. A common polymorphism acts as an intragenic modifier of mutant p53 behaviour. Nat Genet 2000; 25: 47-54.
13. Sabir JSM, El Omri A, Shaik NA, Banaganapalli B, Hajrah NH, Zrelli H, et al. The genetic association study of TP53 polymorphisms in Saudi obese patients. Saudi J Biol Sci 2019; 26: 1338-43.
14. Kodal JB, Vedel-Krogh S, Kobylecki CJ, Nordestgaard BG, Bojesen SE. TP53 Arg72Pro, mortality after cancer, and all-cause mortality in 105,200 individuals. Sci Rep 2017; 7: 336.
15. Sakamuro D, Sabbatini P, White E, Prendergast GC. The polyproline region of p53 is required to activate apoptosis but not growth arrest. Oncogene 1997; 15: 887-98.
16. Kung CP, Murphy ME. The role of the p53 tumor suppressor in metabolism and diabetes. J Endocrinol 2016; 231: R61-R75.
17. Reiling E, Lyssenko V, Boer JM, Imholz S, Verschuren WM, Isomaa B, et al. Codon 72 polymorphism (rs1042522) of TP53 is associated with changes in diastolic blood pressure over time. Eur J Hum Genet 2012; 20: 696-700.
18. Kung CP, Leu JI, Basu S, Khaku S, Anokye-Danso F, Liu Q, et al. The P72R Polymorphism of p53 Predisposes to Obesity and Metabolic Dysfunction. Cell Rep 2016; 14: 2413-25.
19. Bonfigli AR, Sirolla C, Testa R, Cucchi M, Spazzafumo L, Salvioli S, et al. The p53 codon 72 (Arg72Pro) polymorphism is associated with the degree of insulin resistance in type 2 diabetic subjects: a crosssectional study. Acta Diabetol 2013; 50: 429-36.
20. Qu L, He B, Pan Y, Xu Y, Zhu C, Tang Z, et al. Association between polymorphisms in RAPGEF1, TP53, NRF1 and type 2 diabetes in Chinese Han population Diabetes. Res Clin Pract 2011; 91: 171-6.
21. Haghnazari L, Sabzi R. Relationship between TP53 and interleukin-6 gene variants and the risk of types 1 and 2 diabetes mellitus development in the Kermanshah province. J Med Life 2021; 14: 37- 44.

APA	Koc G, SOYOCAK A, Kaya Z, Alis H (2022). The Association Between Arg72Pro C>G Polymorphism in the p53 Gene and the Risk of Obesity. , 55 - 59. 10.4274/imj.galenos.2022.64624
Chicago	Koc Gulsah,SOYOCAK Ahu,Kaya Zehra,Alis Halil The Association Between Arg72Pro C>G Polymorphism in the p53 Gene and the Risk of Obesity. (2022): 55 - 59. 10.4274/imj.galenos.2022.64624
MLA	Koc Gulsah,SOYOCAK Ahu,Kaya Zehra,Alis Halil The Association Between Arg72Pro C>G Polymorphism in the p53 Gene and the Risk of Obesity. , 2022, ss.55 - 59. 10.4274/imj.galenos.2022.64624
AMA	Koc G,SOYOCAK A,Kaya Z,Alis H The Association Between Arg72Pro C>G Polymorphism in the p53 Gene and the Risk of Obesity. . 2022; 55 - 59. 10.4274/imj.galenos.2022.64624
Vancouver	Koc G,SOYOCAK A,Kaya Z,Alis H The Association Between Arg72Pro C>G Polymorphism in the p53 Gene and the Risk of Obesity. . 2022; 55 - 59. 10.4274/imj.galenos.2022.64624
IEEE	Koc G,SOYOCAK A,Kaya Z,Alis H "The Association Between Arg72Pro C>G Polymorphism in the p53 Gene and the Risk of Obesity." , ss.55 - 59, 2022. 10.4274/imj.galenos.2022.64624
ISNAD	Koc, Gulsah vd. "The Association Between Arg72Pro C>G Polymorphism in the p53 Gene and the Risk of Obesity". (2022), 55-59. https://doi.org/10.4274/imj.galenos.2022.64624

APA	Koc G, SOYOCAK A, Kaya Z, Alis H (2022). The Association Between Arg72Pro C>G Polymorphism in the p53 Gene and the Risk of Obesity. İstanbul Medical Journal, 23(1), 55 - 59. 10.4274/imj.galenos.2022.64624
Chicago	Koc Gulsah,SOYOCAK Ahu,Kaya Zehra,Alis Halil The Association Between Arg72Pro C>G Polymorphism in the p53 Gene and the Risk of Obesity. İstanbul Medical Journal 23, no.1 (2022): 55 - 59. 10.4274/imj.galenos.2022.64624
MLA	Koc Gulsah,SOYOCAK Ahu,Kaya Zehra,Alis Halil The Association Between Arg72Pro C>G Polymorphism in the p53 Gene and the Risk of Obesity. İstanbul Medical Journal, vol.23, no.1, 2022, ss.55 - 59. 10.4274/imj.galenos.2022.64624
AMA	Koc G,SOYOCAK A,Kaya Z,Alis H The Association Between Arg72Pro C>G Polymorphism in the p53 Gene and the Risk of Obesity. İstanbul Medical Journal. 2022; 23(1): 55 - 59. 10.4274/imj.galenos.2022.64624
Vancouver	Koc G,SOYOCAK A,Kaya Z,Alis H The Association Between Arg72Pro C>G Polymorphism in the p53 Gene and the Risk of Obesity. İstanbul Medical Journal. 2022; 23(1): 55 - 59. 10.4274/imj.galenos.2022.64624
IEEE	Koc G,SOYOCAK A,Kaya Z,Alis H "The Association Between Arg72Pro C>G Polymorphism in the p53 Gene and the Risk of Obesity." İstanbul Medical Journal, 23, ss.55 - 59, 2022. 10.4274/imj.galenos.2022.64624
ISNAD	Koc, Gulsah vd. "The Association Between Arg72Pro C>G Polymorphism in the p53 Gene and the Risk of Obesity". İstanbul Medical Journal 23/1 (2022), 55-59. https://doi.org/10.4274/imj.galenos.2022.64624